USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	041224/0125			Pages:	5
		Recorded:	02/10/2017
Attorney Dkt #:	153.9999-0000
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 16

Patent #:	8241371	Issue Dt:	08/14/2012	Application #:	12027883	Filing Dt:	02/07/2008
Publication #:	US20080280858	Pub Dt:	11/13/2008
Title:	METHOD OF CREATING CRYSTALLINE SUBSTANCES

Patent #:	8486927	Issue Dt:	07/16/2013	Application #:	12291517	Filing Dt:	11/10/2008
Publication #:	US20090176787	Pub Dt:	07/09/2009
Title:	CRYSTALLINE FORMS OF LAMOTRIGINE

Patent #:	8124603	Issue Dt:	02/28/2012	Application #:	12321525	Filing Dt:	01/22/2009
Publication #:	US20090203680	Pub Dt:	08/13/2009
Title:	IN VIVO STUDIES OF CRYSTALLINE FORMS OF MELOXICAM

Patent #:	8399023	Issue Dt:	03/19/2013	Application #:	12847568	Filing Dt:	07/30/2010
Publication #:	US20110028435	Pub Dt:	02/03/2011
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Patent #:	8586587	Issue Dt:	11/19/2013	Application #:	13203297	Filing Dt:	11/11/2011
Publication #:	US20120046297	Pub Dt:	02/23/2012
Title:	CRYSTALLINE MOLECULAR COMPLEX OF TADALAFIL AND METHYLPARABEN

Patent #:	8980868	Issue Dt:	03/17/2015	Application #:	13387490	Filing Dt:	04/13/2012
Publication #:	US20120190647	Pub Dt:	07/26/2012
Title:	NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE

Patent #:	8389512	Issue Dt:	03/05/2013	Application #:	13399730	Filing Dt:	02/17/2012
Publication #:	US20120149692	Pub Dt:	06/14/2012
Title:	IN VIVO STUDIES OF CRYSTALLINE FORMS OF MELOXICAM

Patent #:	9169279	Issue Dt:	10/27/2015	Application #:	13567827	Filing Dt:	08/06/2012
Publication #:	US20130035315	Pub Dt:	02/07/2013
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Patent #:	8933057	Issue Dt:	01/13/2015	Application #:	13766034	Filing Dt:	02/13/2013
Publication #:	US20140057875	Pub Dt:	02/27/2014
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Patent #:	9334296	Issue Dt:	05/10/2016	Application #:	13826691	Filing Dt:	03/14/2013
Publication #:	US20140107076	Pub Dt:	04/17/2014
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Patent #:	9040535	Issue Dt:	05/26/2015	Application #:	14047463	Filing Dt:	10/07/2013
Publication #:	US20140100233	Pub Dt:	04/10/2014
Title:	CRYSTALLINE MOLECULAR COMPLEXES OF TADALAFIL

Patent #:	9682091	Issue Dt:	06/20/2017	Application #:	14657184	Filing Dt:	03/13/2015
Publication #:	US20150306116	Pub Dt:	10/29/2015
Title:	NOVEL ORAL FORMS OF A PHOSPHONIC ACID DERIVATIVE

Patent #:	NONE	Issue Dt:		Application #:	15132707	Filing Dt:	04/19/2016
Publication #:	US20170022226	Pub Dt:	01/26/2017
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Patent #:	10093691	Issue Dt:	10/09/2018	Application #:	15288139	Filing Dt:	10/07/2016
Publication #:	US20170022227	Pub Dt:	01/26/2017
Title:	CRYSTALLIZATION METHOD AND BIOAVAILABILITY

Assignor

Exec Dt:

12/01/2016

Assignee

ZIEGLERSTRASSE 6

AACHEN, GERMANY 52078

Correspondence name and address
	J.A. LINDEMAN & CO., PLLC
	3190 FAIRVIEW PARK DRIVE
	SUITE 480
	FALLS CHURCH, VA 22042

Search Results as of: 09/22/2024 03:41 PM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6